Earlier this year, BD revealed its intent to split from its lifesciences and diagnostic solutions business to become a pure-play medical device company. On the surface, medtech analysts have largely ...
Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...
BD has inked a technological partnership with automation provider Sinteco, aimed at pharmacy robotics. | The goal is to ...
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...
On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...
FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) ("BD" or the "Company") today announced that the Company's Board of Directors has set the close of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results